InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Tuesday, 04/26/2022 9:27:49 AM

Tuesday, April 26, 2022 9:27:49 AM

Post# of 16698
New F-1/A filing: @ $4.75 USD - Shares are going to more than double with matching warrants that will more than triple the outstanding shares to raise $8,000,000 USD. You are looking at 5 Million+ Fully Diluted Outstanding Shares at the in-the-money stock price of $5.23 USD.

5 Million Shares @ $5.23 USD = $26 Million USD Market Cap.

The company is effectively selling 100 to 1 reverse split shares @ 4 Cents per share. That's what the pending capital raise represents in real world terms for current shareholders.

I'm of the belief today's news release is to circumvent/camouflage/give cover to the latest plan. It was 9 million bid for capital now 8 million bid for capital.

It's my belief that break even for most 100 to 1 pre-reverse split shares is 30 Cent USD. Therefore, at 5 Million Outstanding Shares the company needs a market cap of $150 Million USD/$30 per share.

https://ih.advfn.com/stock-market/USOTC/algernon-pharmaceuticals-qb-AGNPD/stock-news/87896244/securities-registration-foreign-private-issuer-f-1

Best guess is AGNPF will see $2 per share again this year.

M$